In COVID-19, the loss of cytokine production (IL-2, IFNγ or TNFα) [29] and antiviral activity (CD107a and Granzyme B) [32] in both CD4+ and CD8+ T cells may be an important contributing factor to disease severity [21, 30]. The gene discussed is CD4; the disease is COVID-19.